[go: up one dir, main page]

BRPI0507349A - genes associated with canine osteoarthritis and related processes and compositions - Google Patents

genes associated with canine osteoarthritis and related processes and compositions

Info

Publication number
BRPI0507349A
BRPI0507349A BRPI0507349-9A BRPI0507349A BRPI0507349A BR PI0507349 A BRPI0507349 A BR PI0507349A BR PI0507349 A BRPI0507349 A BR PI0507349A BR PI0507349 A BRPI0507349 A BR PI0507349A
Authority
BR
Brazil
Prior art keywords
osteoarthritis
compositions
genes associated
related processes
canine
Prior art date
Application number
BRPI0507349-9A
Other languages
Portuguese (pt)
Inventor
Rondo P Middleton
Steven S Hannah
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0507349A publication Critical patent/BRPI0507349A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

"GENES ASSOCIADOS à OSTEOARTRITE CANINA E PROCESSOS E COMPOSIçõES RELACIONADOS". A presente invenção refere-se a uma combinação contendo moléculas de polinucleotídeos que são expressas diferencialmente na osteoartrite. São descritos ainda os processos que podem ser utilizados para o diagnóstico e para o prognóstico da osteoartrite, assim como os processos que podem ser utilizados para selecionar substâncias de teste em relação à eficiência nas modalidades de tratamento para a osteoartrite. São descritos ainda dispositivos e kits que podem ser utilizados com os processos descritos."GENES ASSOCIATED WITH CANINE OSTEOARTRITE AND RELATED PROCESSES AND COMPOSITIONS". The present invention relates to a combination containing polynucleotide molecules that are differentially expressed in osteoarthritis. Also described are the methods that can be used for the diagnosis and prognosis of osteoarthritis, as well as the methods that can be used to select test substances for the efficiency of osteoarthritis treatment modalities. Devices and kits that can be used with the described processes are further described.

BRPI0507349-9A 2004-02-02 2005-02-02 genes associated with canine osteoarthritis and related processes and compositions BRPI0507349A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54134604P 2004-02-02 2004-02-02
PCT/US2005/003375 WO2005075685A1 (en) 2004-02-02 2005-02-02 Genes associated with canine osteoarthritis and related methods and compositions

Publications (1)

Publication Number Publication Date
BRPI0507349A true BRPI0507349A (en) 2007-04-17

Family

ID=34837479

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0507349-9A BRPI0507349A (en) 2004-02-02 2005-02-02 genes associated with canine osteoarthritis and related processes and compositions

Country Status (9)

Country Link
EP (1) EP1711635A1 (en)
JP (1) JP4879756B2 (en)
CN (1) CN1914336B (en)
AU (1) AU2005210503B2 (en)
BR (1) BRPI0507349A (en)
CA (1) CA2555083A1 (en)
RU (1) RU2341795C2 (en)
WO (1) WO2005075685A1 (en)
ZA (1) ZA200607348B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070118295A1 (en) * 2005-03-02 2007-05-24 Al-Murrani Samer Waleed Khedhe Methods and Systems for Designing Animal Food Compositions
EP2217721A4 (en) * 2007-10-29 2013-01-09 Univ California GENE THERAPY FOR OSTEOARTHRITIS
EP2123775A1 (en) * 2008-05-20 2009-11-25 Stiftung Tierärztliche Hochschule Hannover Analysis for the genetic disposition for hip dysplasia in Canidae
US9464330B2 (en) * 2012-12-21 2016-10-11 Pioneer Hi-Bred International, Inc. Genetic loci associated with soybean cyst nematode resistance and methods of use
CN105803085B (en) * 2016-04-27 2019-07-19 范彧 A kind of molecular marked compound and application thereof detecting osteoarthritis
TWI857807B (en) * 2020-03-20 2024-10-01 台灣粒線體應用技術股份有限公司 Composition containing mitochondria and use thereof as skin fibroblast activity promoter
CN113249464B (en) * 2021-04-13 2022-09-27 广东省中医院（广州中医药大学第二附属医院、广州中医药大学第二临床医学院、广东省中医药科学院） Use of circular RNA as osteoarthritis marker

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0207657A (en) * 2001-02-28 2004-10-26 Chondrogene Inc One or more isolated polynucleotide sequences, vector, host cell, composition, arrangement, methods for diagnosing mild, moderate, severe and severe osteoarthritis in a patient, to identify an agent that increases or decreases the expression of a polynucleotide sequence, to prepare a chondrocyte cdna collection, and to manufacture a disposition, and set

Also Published As

Publication number Publication date
CN1914336A (en) 2007-02-14
AU2005210503A1 (en) 2005-08-18
WO2005075685A1 (en) 2005-08-18
CA2555083A1 (en) 2005-08-18
JP2007523643A (en) 2007-08-23
EP1711635A1 (en) 2006-10-18
CN1914336B (en) 2012-09-19
AU2005210503B2 (en) 2010-02-25
RU2341795C2 (en) 2008-12-20
ZA200607348B (en) 2008-05-28
RU2006131570A (en) 2008-03-10
JP4879756B2 (en) 2012-02-22

Similar Documents

Publication Publication Date Title
BRPI0918670B8 (en) antibody
Li et al. Epigenetic marker (LINE-1 promoter) methylation level was associated with occupational lead exposure
BRPI1013688A8 (en) IL-17 BINDING PROTEINS.
CY1110860T1 (en) REVERSE TRANSLATION OF Poultry Telomerase
CL2012003196A1 (en) Isolated antibody or fragment thereof that specifically binds interleukin-4 (il-4); isolated nucleic acid molecule that encodes it and vector that comprises it; cell comprising said vector; pharmaceutical composition comprising said antibody; and its use to treat an allergic disease, cancer and asthma.
BR112012001984B8 (en) human antibodies with high affinity for human angiopoietin-2, their use and pharmaceutical composition
BR112012032537A2 (en) lung cancer biomarkers and their uses
IN2014DN04226A (en)
EA201301072A1 (en) ANTIBODIES AGAINST IL-23P19 AND THEIR APPLICATION
WO2006117596A8 (en) Nucleic acid probes and nucleic acid analog probes
MX2009009200A (en) Treatment of diseases characterized by inflammation.
CL2008002444A1 (en) Antibody or fragment thereof that binds to human c-fms protein; nucleic acid molecule that encodes it; vector and host cell; production method; pharmaceutical composition comprising it; and its use to treat or prevent a condition associated with c-fms in a patient.
MX2009005781A (en) Oxidation resistant indicator molecules.
AR063493A1 (en) NEW ANTI NOTCH 3 ANTIBODIES AND THEIR USE FOR DETECTION AND DISEASE DIAGNOSIS
MX2018004067A (en) Quencher containing water soluble polymer-conjugated nanomaterial and use thereof.
CL2009000309A1 (en) Aromatic fluoroglycoside derivatives, pharmaceutical composition containing these compounds, procedure to prepare it and its use in the treatment of type 1 and type 2 diabetes.
BR112012029355A2 (en) nucleic acid-based system for propagating information and method for improving nucleic acid-based molecular computing system
DK1994149T3 (en) New fluorescent proteins and methods for their use
BR112015029517A2 (en) method for producing a plurality of measurement regions on a chip and chip with measurement regions
BRPI0507349A (en) genes associated with canine osteoarthritis and related processes and compositions
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
CR9853A (en) EXEMESTANE COMPOUNDS (S) -6-METHYLLOXYALQUIL AND METHODS RELATED TO ITS USE
BRPI0511292A (en) kit to provide a pet meal
BRPI0800673A (en) expression regulatory elements
AR095658A1 (en) METHOD FOR THE PREDICTION OF EXTRAPIRAMIDAL SYMPTOMS (SEP) INDUCED BY AN ANTIPSYCHOTIC-BASED TREATMENT

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 10A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2291 DE 02/12/2014.